Back to Market Feed

Product Information

ACITRETIN 17.5 MG CAPSULE is a generic product labeled by Sigmapharm Laboratories LLC, priced at $4.5839 per EA under NDC 42794008108. Its NADAC has been published 121 times since Sep 2, 2015.

FDA first approved this application on May 22, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ACITRETIN 17.5 MG CAPSULE

ACITRETIN
$4.5839per EA

Strength

17.5 mg/1

NDC

42794008108

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ACITRETIN

Approval Type

Generic (ANDA)

FDA Application

ANDA204633

FDA Approved

5/22/2015

TE Code

AB

On Market Since

9/16/2015

Pharmacological Classes

Retinoid
Retinoids

Price Statistics

The NADAC for ACITRETIN 17.5 MG CAPSULE has been published 121 times since Sep 2, 2015, and over the history we have for it it has declined 81.0%. The table below summarizes its recorded NADAC range and movement.

Current price$4.5839 per EA
All-time high$24.1687 (Mar 16, 2016)
All-time low$4.5839 (Aug 19, 2026)
52-week high$7.9486
52-week low$4.5839
Median price$7.9486
Average price$11.6176
Largest weekly change+55.6% (Jan 21, 2026)
Weeks tracked121
Tracking sinceSep 2, 2015

Price History

1W

-4.6%

1M

-4.6%

3M

-28.0%

6M

-35.1%

1Y

-7.7%

3Y

-81.0%

5Y

-81.0%

All

-81.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ACITRETIN market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
21922005250•Encube Ethicals, Inc.
$0.3288
per GM
ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
45802084601•Padagis Israel Pharmaceuticals Ltd
$0.3288
per GM
ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
51672136403•Sun Pharmaceutical Industries Inc.
$0.3288
per GM
ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
68462030147•Glenmark Pharmaceuticals Inc., USA
$0.3288
per GM
ADAPALENE 0.1% GEL
Generic
00536141226•Rugby Laboratories
$0.3380
per GM
ADAPALENE 0.1% GEL
Generic
51672215006•Sun Pharmaceutical Industries Inc.
$0.3380
per GM
ADAPALENE 0.1% GEL
Generic
00536141220•Rugby Laboratories
$0.4670
per GM
GNP ADAPALENE 0.1% GEL
Generic
46122076836•AmerisourceBergen
$0.4670
per GM
ADAPALENE 0.1% GEL
Generic
51672215001•Sun Pharmaceutical Industries Inc.
$0.4670
per GM
TRETINOIN 0.025% CREAM
Generic
00378808245•Mylan Pharmaceuticals Inc.
$0.4684
per GM

Frequently asked questions

What is the NADAC price of ACITRETIN 17.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ACITRETIN 17.5 MG CAPSULE, manufactured by Sigmapharm Laboratories LLC, is $4.5839 per EA (NDC 42794008108), effective Aug 19, 2026.

How has the price of ACITRETIN 17.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ACITRETIN 17.5 MG CAPSULE has declined 81.0%. It has been tracked across 121 weekly CMS publications since Sep 2, 2015.

What are the highest and lowest recorded NADAC prices for ACITRETIN 17.5 MG CAPSULE?

Since Sep 2, 2015, the NADAC for ACITRETIN 17.5 MG CAPSULE has ranged from a low of $4.5839 (Aug 19, 2026) to a high of $24.1687 (Mar 16, 2016), with a median of $7.9486 per EA.

Are there cheaper alternatives to ACITRETIN 17.5 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of ACITRETIN 17.5 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ACITRETIN 17.5 MG CAPSULE?

ACITRETIN 17.5 MG CAPSULE (NDC 42794008108) is labeled by Sigmapharm Laboratories LLC, and CMS classifies it as a generic product.